This cannot be considered a proof of causality between increased PRL and EDS, but provides an interesting support to our effort to obtain a proof-of-concept from these data and a basis for future controlled studies able to test in a reliable, objective, and methodologically more appropriate way the hypothesis of a role for hyperprolactinemia in EDS. The gene discussed is PRL; the disease is hyperprolactinemia.